This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (347)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Cardiovascular System  • Drug Therapy  • Adverse Effects  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Paul D. Thompson, MD; Priscilla Clarkson, PhD; Richard H. Karas, MD, PhD

JAMA. 2003;289:1681-1690.

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are associated with skeletal muscle complaints, including clinically important myositis and rhabdomyolysis, mild serum creatine kinase (CK) elevations, myalgia with and without elevated CK levels, muscle weakness, muscle cramps, and persistent myalgia and CK elevations after statin withdrawal. We performed a literature review to provide a clinical summary of statin-associated myopathy and discuss possible mediating mechanisms. We also update the US Food and Drug Administration (FDA) reports on statin-associated rhabdomyolysis. Articles on statin myopathy were identified via a PubMed search through November 2002 and articles on statin clinical trials, case series, and review articles were identified via a PubMed search through January 2003. Adverse event reports of statin-associated rhabdomyolysis were also collected from the FDA MEDWATCH database. The literature review found that reports of muscle problems during statin clinical trials are extremely rare. The FDA MEDWATCH Reporting System lists 3339 cases of statin-associated rhabdomyolysis reported between January 1, 1990, and March 31, 2002. Cerivastatin was the most commonly implicated statin. Few data are available regarding the frequency of less-serious events such as muscle pain and weakness, which may affect 1% to 5% of patients. The risk of rhabdomyolysis and other adverse effects with statin use can be exacerbated by several factors, including compromised hepatic and renal function, hypothyroidism, diabetes, and concomitant medications. Medications such as the fibrate gemfibrozil alter statin metabolism and increase statin plasma concentration. How statins injure skeletal muscle is not clear, although recent evidence suggests that statins reduce the production of small regulatory proteins that are important for myocyte maintenance.

Author Affiliations: Preventive Cardiology and Cardiovascular Research, Division of Cardiology, Hartford Hospital, Hartford, Conn (Dr Thompson); Department of Medicine, University of Connecticut, Farmington (Dr Thompson); School of Public Health and Health Sciences and Department of Exercise Science, University of Massachusetts, Amherst (Dr Clarkson); and Preventive Cardiology and Department of Medicine, Tufts University School of Medicine, Tufts–New England Medical Center, Boston, Mass (Dr Karas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Issues in Statin-Associated Myopathy
Join Y. Luh and Bernard M. Karnath
JAMA. 2003;290(7):888.
EXTRACT | FULL TEXT  

Issues in Statin-Associated Myopathy
Mark H. Hyman
JAMA. 2003;290(7):888.
EXTRACT | FULL TEXT  

Detrimental Effect of Statin Therapy in Women With Fibromyalgia
Luca Mascitelli, Francesca Pezzetta, and Mark R. Goldstein
Arch Intern Med. 2008;168(11):1228-1229.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins
Knauer et al.
Circ. Res. 2010;106:297-306.
ABSTRACT | FULL TEXT  

Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil
Bergman et al.
Drug Metab. Dispos. 2009;37:2349-2358.
ABSTRACT | FULL TEXT  

Statins in Acute Coronary Syndromes: Do the Guideline Recommendations Match the Evidence?
Morrissey et al.
J Am Coll Cardiol 2009;54:1425-1433.
ABSTRACT | FULL TEXT  

Biomarkers of Drug-Induced Skeletal Muscle Injury in the Rat: Troponin I and Myoglobin
Vassallo et al.
Toxicol Sci 2009;111:402-412.
ABSTRACT | FULL TEXT  

Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect
Cao et al.
FASEB J. 2009;23:2844-2854.
ABSTRACT | FULL TEXT  

Toxic and drug-induced myopathies
Dalakas
J. Neurol. Neurosurg. Psychiatry 2009;80:832-838.
ABSTRACT | FULL TEXT  

Association between statin-associated myopathy and skeletal muscle damage
Mohaupt et al.
CMAJ 2009;181:E11-E18.
ABSTRACT | FULL TEXT  

The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise
Robinson et al.
J. Appl. Physiol. 2009;107:8-16.
ABSTRACT | FULL TEXT  

Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
Becker et al.
ANN INTERN MED 2009;150:830-839.
ABSTRACT | FULL TEXT  

Narrative Review: Statin-Related Myopathy
Joy and Hegele
ANN INTERN MED 2009;150:858-868.
ABSTRACT | FULL TEXT  

Elevated creatine phosphokinase levels associated with linezolid therapy
Allison et al.
Am J Health Syst Pharm 2009;66:1097-1100.
ABSTRACT | FULL TEXT  

Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings
Mosshammer et al.
Fam Pract 2009;26:88-95.
ABSTRACT | FULL TEXT  

Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
Heart Protection Study Collaborative Group
Circ Cardiovasc Qual Outcomes 2009;2:65-72.
ABSTRACT | FULL TEXT  

Hepatitis, rhabdomyolysis and multi-organ failure resulting from statin use
Rajaram
BMJ Case Reports 2009;2009:bcr0720080412-bcr0720080412.
ABSTRACT | FULL TEXT  

Rhabdomyolysis associated with the nutritional supplement Hydroxycut
Dehoney and Wellein
Am J Health Syst Pharm 2009;66:142-148.
ABSTRACT | FULL TEXT  

Hypothermia, Hyperthermia, and Rhabdomyolysis
Zimmerman
ACCP Crit Care Med Brd Rev 2009;20:321-332.
FULL TEXT  

The battle to keep or lose skeletal muscle with ageing
Kjaer and Jespersen
J. Physiol. 2009;587:1-2.
FULL TEXT  

Is There a Problem With Ezetimibe or Just ENHANCEd Hype?
Whayne
ANGIOLOGY 2009;59:661-663.
 

Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy
Mallinson et al.
J. Physiol. 2009;587:219-230.
ABSTRACT | FULL TEXT  

Fluvastatin, Rhabdomyolysis, and Myotoxicity
Murinson and Maragakis
Mayo Clin Proc. 2008;83:1296-1296.
FULL TEXT  

Is Red Yeast Rice a Suitable Alternative for Statins?-Reply-I
Becker et al.
Mayo Clin Proc. 2008;83:1294-1296.
FULL TEXT  

Pharmacogenomics: candidate gene identification, functional validation and mechanisms
Wang and Weinshilboum
Hum Mol Genet 2008;17:R174-R179.
ABSTRACT | FULL TEXT  

SLCO1B1 Variants and Statin-Induced Myopathy -- A Genomewide Study
The SEARCH Collaborative Group
NEJM 2008;359:789-799.
ABSTRACT | FULL TEXT  

Lipidomics-Based Safety Biomarkers for Lipid-Lowering Treatments
Laaksonen et al.
ANGIOLOGY 2008;59:65S-68S.
ABSTRACT  

Detrimental Effect of Statin Therapy in Women With Fibromyalgia
Mascitelli et al.
Arch Intern Med 2008;168:1228-1229.
FULL TEXT  

Toward 'Pain-Free' Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia
Jacobson
Mayo Clin Proc. 2008;83:687-700.
ABSTRACT | FULL TEXT  

Rhabdomyolysis with atorvastatin and fusidic acid
O'Mahony et al.
Postgrad. Med. J. 2008;84:325-327.
ABSTRACT | FULL TEXT  

Rosuvastatin: Characterization of Induced Myopathy in the Rat
Westwood et al.
Toxicol Pathol 2008;36:345-352.
ABSTRACT | FULL TEXT  

Deletion of the Selenocysteine tRNA Gene in Macrophages and Liver Results in Compensatory Gene Induction of Cytoprotective Enzymes by Nrf2
Suzuki et al.
J. Biol. Chem. 2008;283:2021-2030.
ABSTRACT | FULL TEXT  

Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Ferdinandy et al.
Pharmacol. Rev. 2007;59:418-458.
ABSTRACT | FULL TEXT  

Letter to the Editor: Does Statin Therapy Interfere With the Ability of Claudicant Patients to Exercise?
Mascitelli et al.
VASC ENDOVASCULAR SURG 2007;41:473-473.
 

Acute Renal Failure and Myalgia in a Transplant Patient
Najafian et al.
J. Am. Soc. Nephrol. 2007;18:2870-2874.
ABSTRACT | FULL TEXT  

Statins and Dietary and Serum Cholesterol Are Associated With Increased Lean Mass Following Resistance Training
Riechman et al.
J Gerontol A Biol Sci Med Sci 2007;62:1164-1171.
ABSTRACT | FULL TEXT  

Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights From Large Randomized Statin Trials
Alsheikh-Ali et al.
J Am Coll Cardiol 2007;50:409-418.
ABSTRACT | FULL TEXT  

The Role of Coenzyme Q10 in Statin-Associated Myopathy: A Systematic Review
Marcoff and Thompson
J Am Coll Cardiol 2007;49:2231-2237.
ABSTRACT | FULL TEXT  

Skeletal Muscle Susceptibility to Clofibrate Induction of Lesions in Rats
Okada et al.
Toxicol Pathol 2007;35:517-520.
ABSTRACT | FULL TEXT  

Atorvastatin-induced early-onset rhabdomyolysis in a patient with nephrotic syndrome
Jose et al.
Am J Health Syst Pharm 2007;64:726-729.
ABSTRACT | FULL TEXT  

Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease
Kwan et al.
J. Am. Soc. Nephrol. 2007;18:1246-1261.
FULL TEXT  

Asymptomatic hypothyroidism and statin-induced myopathy
Bar et al.
cfp 2007;53:428-431.
FULL TEXT  

The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
Belay et al.
Pediatrics 2007;119:370-380.
ABSTRACT | FULL TEXT  

Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani et al.
Circulation 2006;114:2788-2797.
ABSTRACT | FULL TEXT  

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people
Heart Protection Study Collaborative
BMJ 2006;333:1145-1145.
ABSTRACT | FULL TEXT  

Atherosclerotic vascular disease in systemic lupus erythematosus and related disorders
La Rosa
Lupus 2006;15:35-38.
ABSTRACT  

Peroxisome Proliferator-Activated Receptors at the Crossroads of Obesity, Diabetes, and Cardiovascular Disease
Gilde et al.
J Am Coll Cardiol 2006;48:A24-A32.
ABSTRACT | FULL TEXT  

Drug Interactions of Medications Commonly Used in Diabetes
Triplitt
Diabetes Spectr. 2006;19:202-211.
FULL TEXT  

The Argument Against the Appropriateness of Over-the-Counter Statins
Barter and Rye
Circulation 2006;114:1315-1320.
FULL TEXT  

Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver
Okazaki et al.
J. Lipid Res. 2006;47:1950-1958.
ABSTRACT | FULL TEXT  

Overprescribing of lipid lowering agents.
Smith et al.
Qual Saf Health Care 2006;15:251-257.
ABSTRACT | FULL TEXT  

Presymptomatic neuromuscular disorders disclosed following statin treatment.
Tsivgoulis et al.
Arch Intern Med 2006;166:1519-1524.
ABSTRACT | FULL TEXT  

A 39-year-old woman with hypercholesterolemia.
Mittleman
JAMA 2006;296:319-326.
ABSTRACT | FULL TEXT  

Statin-related myopathy.
Dobkin
Arch Intern Med 2006;166:1232-1232.
FULL TEXT  

Observations From a Statin Myopathy Clinic--Reply
Hansen et al.
Arch Intern Med 2006;166:1233-1233.
FULL TEXT  

Statin-Induced Myopathy: The Two Faces of Janus
Arora et al.
J CARDIOVASC PHARMACOL THER 2006;11:105-112.
ABSTRACT  

Case 4-2006 -- A 79-Year-Old Woman with Myalgias, Fatigue, and Shortness of Breath
Kay et al.
NEJM 2006;354:623-630.
FULL TEXT  

Drug induced myopathies
Mastaglia
PN 2006;6:4-13.
FULL TEXT  

Outcomes in 45 Patients With Statin-Associated Myopathy
Hansen et al.
Arch Intern Med 2005;165:2671-2676.
ABSTRACT | FULL TEXT  

Roles of Exercise and Pharmacokinetics in Cerivastatin-Induced Skeletal Muscle Toxicity
Seachrist et al.
Toxicol Sci 2005;88:551-561.
ABSTRACT | FULL TEXT  

Disease modification and cardiovascular risk reduction: two sides of the same coin?
Hall and Dalbeth
Rheumatology (Oxford) 2005;44:1473-1482.
ABSTRACT | FULL TEXT  

Muscle Coenzyme Q10 Level in Statin-Related Myopathy
Lamperti et al.
Arch Neurol 2005;62:1709-1712.
ABSTRACT | FULL TEXT  

Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy: A PROVE IT-TIMI 22 Substudy
Wiviott et al.
J Am Coll Cardiol 2005;46:1411-1416.
ABSTRACT | FULL TEXT  

Differential Association Between Statin Exposure and Elevated Levels of Creatine Kinase
Chan et al.
The Annals of Pharmacotherapy 2005;39:1611-1615.
ABSTRACT | FULL TEXT  

Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Dobkin
Neurorehabil Neural Repair 2005;19:259-263.
ABSTRACT  

Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study
Krasuski et al.
Mayo Clin Proc. 2005;80:1163-1168.
ABSTRACT  

The Safety of Rosuvastatin as Used in Common Clinical Practice: A Postmarketing Analysis
Alsheikh-Ali et al.
Circulation 2005;111:3051-3057.
ABSTRACT | FULL TEXT  

Rhabdomyolysis with Cardiac Involvement and Acute Renal Failure in a Patient Taking Rosuvastatin and Fenofibrate
Ireland et al.
ANN INTERN MED 2005;142:949-950.
FULL TEXT  

Management of mixed hyperlipidaemia
Stalenhoef
Eur Heart J 2005;26:856-857.
FULL TEXT  

Potential Adverse Effects of Statins on Muscle
Tomlinson and Mangione
ptjournal 2005;85:459-465.
FULL TEXT  

Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
Cafforio et al.
Carcinogenesis 2005;26:883-891.
ABSTRACT | FULL TEXT  

Exertion-induced rhabdomyolysis in a patient on statin therapy
Unnikrishnan and Satish
Nephrol Dial Transplant 2005;20:244-244.
FULL TEXT  

Acute Rhabdomyolysis Associated with Ofloxacin/Levofloxacin Therapy
Hsiao et al.
The Annals of Pharmacotherapy 2005;39:146-149.
ABSTRACT | FULL TEXT  

Other therapy options and future strategies for treating patients with multiple sclerosis
Rizvi and Bashir
Neurology 2004;63:S47-S54.
ABSTRACT | FULL TEXT  

Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs
Graham et al.
JAMA 2004;292:2585-2590.
ABSTRACT | FULL TEXT  

Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
Psaty et al.
JAMA 2004;292:2622-2631.
ABSTRACT | FULL TEXT  

Robin Goodfellow (43-10)
Rheumatology (Oxford) 2004;43:1319-1319.
FULL TEXT  

High-Dose Statins in Acute Coronary Syndromes: Not Just Lipid Levels
Nissen
JAMA 2004;292:1365-1367.
FULL TEXT  

Role of statin therapy in the coronary bypass patient
Lazar
Ann. Thorac. Surg. 2004;78:730-740.
ABSTRACT | FULL TEXT  

Rosuvastatin (Crestor) and rhabdomyolysis
Wooltorton
CMAJ 2004;171:129-129.
FULL TEXT  

Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts
da Costa et al.
Am. J. Clin. Nutr. 2004;80:163-170.
ABSTRACT | FULL TEXT  

Low-dose statins: useful and safe?
Schachter
British Journal of Diabetes & Vascular Disease 2004;4:260-262.
ABSTRACT  

CT of Coronary Artery Disease
Schoepf et al.
Radiology 2004;232:18-37.
ABSTRACT | FULL TEXT  

Rhabdomyolysis Caused by Commiphora mukul, a Natural Lipid-Lowering Agent
Bianchi et al.
The Annals of Pharmacotherapy 2004;38:1222-1225.
ABSTRACT | FULL TEXT  

Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta et al.
Circulation 2004;109:III-50-III-57.
ABSTRACT | FULL TEXT  

Rhabdomyolysis in Association with Simvastatin and Amiodarone
Roten et al.
The Annals of Pharmacotherapy 2004;38:978-981.
ABSTRACT | FULL TEXT  

Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells
Pouvreau et al.
J. Physiol. 2004;555:365-381.
ABSTRACT | FULL TEXT  

Statin-associated rhabdomyolysis triggered by grapefruit consumption
Dreier and Endres
Neurology 2004;62:670-670.
FULL TEXT  

Rhabdomyolysis and Renal Failure Associated with Gemfibrozil Monotherapy
Layne et al.
The Annals of Pharmacotherapy 2004;38:232-234.
ABSTRACT | FULL TEXT  

Statin Treatment in Diabetes Mellitus
Buse
Clin. Diabetes 2003;21:168-172.
FULL TEXT  

Issues in Statin-Associated Myopathy
Luh and Karnath
JAMA 2003;290:888-888.
FULL TEXT  

Issues in Statin-Associated Myopathy
Hyman
JAMA 2003;290:888-888.
FULL TEXT